Lauren Park

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Emergency Department

Genetic Diversity

Top Venues

Circulation. Genomic and precision medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Josephin Wagner, Pal Pacher, David W Ray, George Davey Smith, Falk W Lohoff
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. Circulation. Genomic and precision medicine 17 (1) (2024)
Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Josephin Wagner, Pal Pacher, David W Ray, George Davey Smith, Falk W Lohoff
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. Circulation. Genomic and precision medicine 17 (1) (2024)
Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Josephin Wagner, Pal Pacher, David W Ray, George Davey Smith, Falk W Lohoff
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. Circulation. Genomic and precision medicine 17 (1) (2024)
Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Josephin Wagner, Pal Pacher, David W Ray, George Davey Smith, Falk W Lohoff
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. Circulation. Genomic and precision medicine 17 (1) (2024)
Daniel B Rosoff, Andrew S Bell, Lucas A Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Josephin Wagner, Pal Pacher, David W Ray, George Davey Smith, Falk W Lohoff
Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. Circulation. Genomic and precision medicine (2024)